Market Place
Sourcing Support
Affinia Therapeutic Appoint Hideo Makimura as Chief Medical Officer
05 Feb 2025 //
PR NEWSWIRE
Affinia Announces BAG3 DCM Candidate, Completes Pre-IND FDA Meeting
09 Jan 2025 //
PR NEWSWIRE
Affinia To Highlight Data On Genetic Cardiomyopathy At ESGCT 2024
22 Oct 2024 //
PR NEWSWIRE
Affinia Therapeutics Names New Chief Business & Financial Officer
10 Sep 2024 //
CONTRACT PHARMA
Affinia`s Novel AAV Capsids, Cardiomyopathy/ALS Data At ASGCT
22 Apr 2024 //
PR NEWSWIRE
Affinia Therapeutics Presents New Data at ASGCT
16 May 2022 //
PRNEWSWIRE
Gene therapy player Affinia aims to go public
06 Jan 2022 //
ENDPTS
Affinia Therapeutics Appoints Thomas Leggett as CFO
14 Dec 2021 //
GLOBENEWSWIRE
Affinia Therapeutics Appoints Carole Faig to Board of Directors
06 Oct 2021 //
GLOBENEWSWIRE
Affinia Announces Indications for Lead Gene Programscturing Agreement Lonza
08 Sep 2021 //
BIOSPACE
Affinia Therapeutics Presents New Data and Updates on AAV Platform
13 May 2021 //
GLOBENEWSWIRE
Affinia Therapeutics raises $110 million for gene therapy treatments
05 May 2021 //
STATNEWS
Gene therapy biotech Affinia prepares for clinic with $110M financing
03 May 2021 //
FIERCEBIOTECH
Affinia Raises $60M in Series A to Advance Rational Design AAV Platform
15 May 2020 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.